Paper
8 January 2024 Coenzyme Q10: Does it benefit neurological diseases?
Tianle Chen
Author Affiliations +
Proceedings Volume 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023); 129242O (2024) https://doi.org/10.1117/12.3012862
Event: 3rd International Conference on Biological Engineering and Medical Science (ICBioMed2023), 2023, ONLINE, United Kingdom
Abstract
Coenzyme Q10 (CoQ10), a redox-active lipid with significant hydrophobic properties, has been found to have lower levels detected in tissues and organs of individuals with certain chronic diseases. This observation has led to the hypothesis that supplementing Coenzyme Q10 can alleviate symptoms of aging and/or delay the onset of these diseases. As a result, there appears to be a positive influence of CoQ10 in certain neurological diseases, including Alzheimer disease, seizures, amyotrophic lateral sclerosis, and multiple sclerosis. This review would discuss the current complementary methods of CoQ10 and explore its therapeutic potential in the treatment of neurological diseases.
(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Tianle Chen "Coenzyme Q10: Does it benefit neurological diseases?", Proc. SPIE 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), 129242O (8 January 2024); https://doi.org/10.1117/12.3012862
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
Back to Top